1. Lee WY. Endocrinology and Metabolism is indexed in the emerging sources citation index. Endocrinol Metab (Seoul). 2017; 32:350–352. PMID:
28956364.
Article
2. Trimboli P, Giovanella L. Procalcitonin as marker of recurrent medullary thyroid carcinoma: a systematic review and meta-analysis. Endocrinol Metab (Seoul). 2018; 22:204–210.
Article
3. Hong N, Lee Y, Tsujita K, Gonzalez JA, Kramer CM, Kovarnik T, et al. Comparison of the effects of ezetimibe-statin combination therapy on major adverse cardiovascular events in patients with and without diabetes: a meta-analysis. Endocrinol Metab (Seoul). 2018; 22:219–227.
Article
4. Hyun KR, Kang S, Lee S. Cost-of-illness trends associated with thyroid disease in Korea. Endocrinol Metab (Seoul). 2014; 29:257–269. PMID:
25309784.
Article
5. Sohn SY, Jang HW, Cho YY, Kim SW, Chung JH. Economic evaluation of recombinant human thyroid stimulating hormone stimulation vs. thyroid hormone withdrawal prior to radioiodine ablation for thyroid cancer: the Korean perspective. Endocrinol Metab (Seoul). 2015; 30:531–542. PMID:
26394733.
Article
6. International Committee of Medical Journal Editors. Recommendations [Internet]. ICMJE: c2018. cited 2018 Jun 7. Available from:
http://icmje.org/recommendations.